Immunocore Holdings (IMCR) Receivables - Net (2019 - 2025)
Immunocore Holdings (IMCR) has disclosed Receivables - Net for 7 consecutive years, with $74.0 million as the latest value for Q4 2025.
- Quarterly Receivables - Net rose 17.41% to $74.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $74.0 million through Dec 2025, up 17.41% year-over-year, with the annual reading at $74.0 million for FY2025, 17.41% up from the prior year.
- Receivables - Net hit $74.0 million in Q4 2025 for Immunocore Holdings, down from $75.9 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $75.9 million in Q3 2025 to a low of $8.2 million in Q4 2021.
- Historically, Receivables - Net has averaged $56.4 million across 5 years, with a median of $63.0 million in 2024.
- Biggest five-year swings in Receivables - Net: tumbled 39.95% in 2021 and later surged 299.1% in 2022.
- Year by year, Receivables - Net stood at $8.2 million in 2021, then soared by 299.1% to $32.5 million in 2022, then soared by 60.13% to $52.1 million in 2023, then increased by 20.95% to $63.0 million in 2024, then increased by 17.41% to $74.0 million in 2025.
- Business Quant data shows Receivables - Net for IMCR at $74.0 million in Q4 2025, $75.9 million in Q3 2025, and $69.8 million in Q2 2025.